OWG
HALO icon

Oxford Wealth Group’s Halozyme HALO Stock Holding History

Oxford Wealth Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482K Sell
6,162
-561
-8% -$38.3K 0.22% 61
2026
Q1 		$435K Buy
6,723
+53
+0.8% +$3.74K 0.24% 61
2025
Q4 		$449K Buy
+6,670
New +$449K 0.22% 62

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Oxford Wealth Group's HALO Position: Q2 2026 in Review

Oxford Wealth Group reduced its Halozyme (HALO) stake by 8.3% in Q2 2026, selling an estimated $38.3K and leaving 6,162 shares worth $482K. The position accounts for 0.22% of the portfolio, ranked #61.

Oxford Wealth Group first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Oxford Wealth Group held 6,162 shares of Halozyme worth $482K as of Q2 2026.
  • Oxford Wealth Group sold 561 Halozyme shares in Q2 2026, an estimated $38.3K.
  • Halozyme made up 0.22% of Oxford Wealth Group's portfolio in Q2 2026, its #61 holding.
  • Oxford Wealth Group first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
  • 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Oxford Wealth Group's 13F filing for Q2 2026, filed 13 Aug 2026.